1800-272-662
Shopping Cart 0
countryflagAU
Login

Medipharm Labs Corp

Healthcare CA LABS

0.07CAD
-(-%)

Last update at 2026-03-10T20:00:00Z

Day Range

0.070.07
LowHigh

52 Week Range

0.060.12
LowHigh

Fundamentals

  • Previous Close 0.07
  • Market Cap29.45M
  • Volume177937
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-4.84300M
  • Revenue TTM46.10M
  • Revenue Per Share TTM0.11
  • Gross Profit TTM 13.96M
  • Diluted EPS TTM-0.03

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -10.69400M -13.35900M -29.98900M -54.68800M -72.10000M
Minority interest - - - 0.00000M 0.76M
Net income -10.69400M -13.08300M -29.98300M -54.80100M -67.11000M
Selling general administrative 19.81M 21.64M 18.45M 18.40M 24.59M
Selling and marketing expenses 3.04M 3.16M 6.30M 4.63M 4.37M
Gross profit 12.80M 5.86M -1.91400M -15.24600M -43.97800M
Reconciled depreciation 2.60M 2.52M 2.87M 5.63M 10.81M
Ebit -10.11800M -12.99400M -29.53300M -48.91600M -72.57600M
Ebitda -7.51800M -10.47800M -25.44000M -37.15100M -59.94800M
Depreciation and amortization 2.60M 2.52M 4.09M 11.77M 12.63M
Non operating income net other - - - - -
Operating income -10.80900M -18.25200M -29.53300M -48.91600M -72.57600M
Other operating expenses 52.77M 51.31M 50.91M 64.72M 107.04M
Interest expense 0.58M 0.36M 0.03M 10.51M 7.88M
Tax provision 0.00000M -0.27600M -0.00600M 0.11M -4.99000M
Interest income 0.12M 0.84M 0.46M 5.77M 7.56M
Net interest income 0.12M 0.47M 0.45M -10.28100M -7.60200M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -0.27600M -0.00600M 0.11M -4.99000M
Total revenue 41.96M 33.06M 22.12M 21.71M 36.01M
Total operating expenses 23.61M 24.11M 26.88M 27.76M 27.05M
Cost of revenue 29.16M 27.21M 24.03M 36.96M 79.99M
Total other income expense net 0.12M 4.89M -0.45600M -5.77200M 0.48M
Discontinued operations - - - - -
Net income from continuing ops -10.69400M -13.08300M -29.98300M -54.80100M -67.11000M
Net income applicable to common shares -10.69400M -13.08300M -29.98300M -54.80100M -66.35300M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 53.73M 63.94M 65.50M 92.36M 118.23M
Intangible assets 0.85M 1.03M 0.04M 0.04M 0.23M
Earning assets - - - - -
Other current assets 0.21M 2.89M 2.27M 4.75M 4.59M
Total liab 10.55M 10.93M 9.49M 9.21M 39.82M
Total stockholder equity 43.18M 53.01M 56.01M 83.15M 78.41M
Deferred long term liab - - - - -
Other current liab - 6.39M 4.00M 4.45M 19.99M
Common stock - 200.24M 191.26M 190.55M 138.51M
Capital stock 201.21M 200.24M 191.26M 190.55M 138.51M
Retained earnings -187.42600M -176.73200M -163.64900M -129.34300M -74.54200M
Other liab - - - 0.23M 4.81M
Good will - - - - -
Other assets - 0.00000M 0.00000M 0.88M 2.15M
Cash 11.69M 17.98M 24.14M 34.11M 19.91M
Cash and equivalents - - 24.14M 34.11M 19.91M
Total current liabilities 10.49M 10.86M 9.46M 8.88M 24.25M
Current deferred revenue - 0.11M 1.32M 1.32M 1.00M
Net debt - -15.68600M -23.51300M -33.89400M -1.45500M
Short term debt - 2.23M 0.60M 0.11M 7.70M
Short long term debt 0.26M 2.10M 0.52M - 7.38M
Short long term debt total - 2.29M 0.63M 0.22M 18.46M
Other stockholder equity - - 0.00000M 21.94M 14.45M
Property plant equipment - - 18.11M 25.89M 34.14M
Total current assets 33.08M 36.63M 47.34M 65.55M 81.52M
Long term investments - - - 0.00000M 0.19M
Net tangible assets - - - 83.10M 78.19M
Short term investments - 0.27M - - -
Net receivables 6.88M 5.87M 13.15M 17.35M 34.88M
Long term debt - - - 0.00000M 10.54M
Inventory 8.71M 9.90M 7.78M 10.98M 22.14M
Accounts payable 4.24M 2.13M 3.54M 2.99M 5.55M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 29.49M 28.40M 21.94M 14.45M
Additional paid in capital - - - - -
Common stock total equity - - - - 138.51M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 1.00M - 0.88M 2.10M
Deferred long term asset charges - - - - -
Non current assets total 20.65M 27.30M 18.15M 26.81M 36.71M
Capital lease obligations 0.13M 0.19M 0.11M 0.22M 0.54M
Long term debt total - - 0.03M 0.10M 10.76M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments 0.41M 6.87M 5.16M 0.04M -0.00200M
Change to liabilities - - - -8.10700M -4.57000M
Total cashflows from investing activities 0.41M 6.87M 5.16M 0.04M -7.44600M
Net borrowings -2.25200M -0.94400M - -2.96200M 22.08M
Total cash from financing activities -1.84700M -0.36800M 0.80M 27.80M 26.42M
Change to operating activities - - - 1.79M -1.07600M
Net income -10.69400M -13.08300M -29.98300M -54.80100M -67.11000M
Change in cash -6.29100M -6.16400M -9.96500M 14.20M -18.71400M
Begin period cash flow 17.98M 24.14M 34.11M 19.91M 38.63M
End period cash flow 11.69M 17.98M 24.14M 34.11M 19.91M
Total cash from operating activities -4.86100M -12.33900M -16.06900M -13.21300M -37.77300M
Issuance of capital stock - - 0.00000M 30.92M -
Depreciation 2.60M 2.52M 2.87M 5.63M 10.81M
Other cashflows from investing activities 0.57M 2.08M 6.02M 0.82M 0.06M
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change to inventory 0.80M 3.11M -0.10300M 11.16M 29.41M
Change to account receivables -1.56300M 6.42M 3.62M 12.73M -2.08900M
Sale purchase of stock 0.01M - 0.00000M 30.92M 5.31M
Other cashflows from financing activities 0.39M 0.58M 1.74M -0.15100M 40.48M
Change to netincome - - - 14.13M 0.71M
Capital expenditures 0.15M 0.47M 0.86M 0.78M 7.50M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 1.65M 3.45M 6.25M 21.83M 17.06M
Stock based compensation 0.98M 2.03M 2.87M 2.40M 2.68M
Other non cash items 0.60M -7.24900M 1.93M 11.61M 3.66M
Free cash flow -5.01500M -12.81000M -16.93200M -13.99600M -45.27600M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
LABS
Medipharm Labs Corp		 - -% 0.07 - 27.47 0.64 0.78 0.42 -1.8196
BHC
Bausch Health Companies Inc		 0.08 1.10% 7.33 5.94 1.34 0.29 18.74 2.18 6.64
CURA
Curaleaf Holdings Inc.		 0.02 0.65% 3.08 - 138.89 1.90 2.05 1.88 11.75
CRON
Cronos Group Inc		 0.01 0.29% 3.44 23.40 32.26 10.16 0.92 1.27 -1.9458
TLRY
Tilray Inc		 -0.14 1.40% 9.83 - 1000.00 1.34 0.56 1.09 -2.299

Reports Covered

Stock Research & News

View All

Profile

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, develops, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll cannabis products. In addition, the company offers cannabis related medical information and services; and medical cannabis clinic services. MediPharm Labs Corp. was founded in 2015 and is based in Barrie, Canada.

Medipharm Labs Corp

151 John Street, Barrie, ON, Canada, L4N 2L1

Key Executives

Name Title Year Born
Mr. Keith Strachan Co-Founder & Pres NA
Mr. Greg Hunter Chief Financial Officer NA
Mr. David A. Pidduck CEO & Director NA
Mr. Patrick McCutcheon Founder NA
Mr. Saravan Subramaniam VP of Operations & Supply Chain NA
Mr. Geoffrey Marr Exec. VP & Gen. Counsel NA
Mr. Brett Moon VP of Sales NA
Mr. Kirk Binns Exec. VP of Global Accounts NA
Mr. Nigel Dewsbury Head of Quality NA
Mr. Keith Strachan Co-Founder & President NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.